DENNIS D KIM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DENNIS D KIM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DENNIS D KIM. DENNIS D KIM is a Chief Medical Officer in ZAFGEN, INC. ($ZFGN) and a Sr. VP, Corporate Development in Orexigen Therapeutics, Inc. ($OREX) and a Chief Medical Officer in Emerald Bioscience, Inc. ($NMUS).
Address: C/O OREXIGEN THERAPEUTICS, INC. 3344 N. TORREY PINES COURT, SUITE 200 LA JOLLA 92037 CA
Companies in which DENNIS D KIM is an Insider
Larimar Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DENNIS D KIM: Chief Medical Officer
Holdings: 21,443 shares
Current Value: $87,916
Latest Transaction: Jan 24 2019
$LRMR Market Capitalization: $109.05M
$LRMR Previous Close: $4.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Orexigen Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DENNIS D KIM: Sr. VP, Corporate Development
Holdings: 25,200 shares
Current Value: $115,416
Latest Transaction: Apr 27 2009
$OREX Market Capitalization: $70.30M
$OREX Previous Close: $4.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Skye Bioscience, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DENNIS D KIM: Chief Medical Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 11 2020
$NMUS Market Capitalization: $8.53M
$NMUS Previous Close: $0.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DENNIS D KIM
Sentiment: All, LRMR, OREX, NMUS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11 2020 | NMUS | Emerald Bioscience ... | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 0.05 | 4,000,000 | 180,000 | 4,736,541 | |
| Aug 23 2019 | NMUS | Emerald Bioscience ... | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 0.30 | 736,541 | 220,962 | 736,541 | |
| Aug 23 2019 | NMUS | Emerald Bioscience ... | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 0.30 | 736,541 | 220,962 | 736,541 | |
| Jan 24 2019 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 4.63 | 95,000 | 439,850 | 95,000 | |
| Feb 23 2018 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 7.77 | 125,000 | 971,250 | 125,000 | |
| Jul 12 2017 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Buy | P | 3.39 | 10,000 | 33,900 | 21,443 | 11.4 K to 21.4 K (+87.39 %) |
| May 11 2017 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Buy | P | 4.40 | 9,800 | 43,120 | 11,443 | 1.6 K to 11.4 K (+596.47 %) |